Open AccessTreatment Outcomes of Topical Calcineurin Inhibitor Therapy for Patients With Vitiligo
Author(s) -
Ji Hae Lee,
Kwon Yoo,
Han Mi Jung,
H. Lee,
Gyong Moon Kim,
Hyeon Woo Yim,
Jung Min Bae
Publication year - 2019
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2019.0696
Subject(s) - medicine , calcineurin , vitiligo , dermatology , tacrolimus , pimecrolimus , pharmacology , transplantation
Topical calcineurin inhibitors (TCIs), including tacrolimus and pimecrolimus, have been widely used for the treatment of vitiligo; however, the efficacy of TCI monotherapy is often underestimated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom